BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 26844688)

  • 1. Effect of Low Dose Oral Vitamin-D and Calcium Replacement in HIV Patients.
    Das S; Bopitya S; Chowdhury AR; Das A; Taha H
    Recent Pat Antiinfect Drug Discov; 2016; 11(1):59-67. PubMed ID: 26844688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Low Dose Oral Vitamin D on Bone Mineral Density Changes in HIV Patients: 36 Months Follow Up.
    Dhother J; Bopitiya S; Taha H; Das S
    Infect Disord Drug Targets; 2020; 20(5):651-658. PubMed ID: 31258093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between vitamin D, parathyroid hormone, bone mineral density, fracture and antiretroviral therapy in HIV patients.
    Das S; Bopitya S; Taha H; David L
    Recent Pat Antiinfect Drug Discov; 2014; 9(1):6-13. PubMed ID: 24909536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone mass preservation with high-dose cholecalciferol and dietary calcium in HIV patients following antiretroviral therapy. Is it possible?
    Mela Q; Ruggiero V; Montaldo L; Pisano U; Matta L; Maria Pasetto C; Onali S; Cacace E; Carta MG; Barca L; Chessa L
    HIV Clin Trials; 2018 Oct; 19(5):188-196. PubMed ID: 30445888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone Mineral Density and Vitamin D Levels in HIV Treatment-Naïve African American Individuals Randomized to Receive HIV Drug Regimens.
    Cook PP; Stang AT; Walker LR; Akula SM; Cook FJ
    South Med J; 2016 Nov; 109(11):712-717. PubMed ID: 27812717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D status and parathyroid hormone levels in relation to bone mineral density in apparently healthy Syrian adults.
    Sayed-Hassan R; Abazid N; Koudsi A; Alourfi Z
    Arch Osteoporos; 2016; 11():18. PubMed ID: 27126333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between vitamin D metabolites, antiretroviral therapy and bone mineral density in people with HIV.
    Klassen KM; Kimlin MG; Fairley CK; Emery S; Anderson PH; Ebeling PR;
    Osteoporos Int; 2016 May; 27(5):1737-45. PubMed ID: 26659069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Impact of Calcium and Vitamin D Supplementation on Bone Density in HIV
    Faber J; Bech A; van Bentum P; Gisolf J; Hassing RJ; de Boer H
    AIDS Res Hum Retroviruses; 2020 Jan; 36(1):58-64. PubMed ID: 31523978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.
    Meier C; Woitge HW; Witte K; Lemmer B; Seibel MJ
    J Bone Miner Res; 2004 Aug; 19(8):1221-30. PubMed ID: 15231008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between increased endogenous parathormone levels and bone density in postmenopausal women treated with bisphosphonates.
    Coin A; Veronese N; Bolzetta F; De Rui M; Manzato E; Sergi G
    Panminerva Med; 2012 Dec; 54(4):277-82. PubMed ID: 23123579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of risedronate with cholecalciferol on bone mineral density in Korean patients with osteoporosis.
    Park SY; Kang MI; Park HM; Rhee Y; Moon SH; Yoon HK; Koh JM; Chang JS; Kim IJ; Won YY; Park YS; Choi H; Shin CS; Yoon TR; Yun SC; Chung HY;
    Arch Osteoporos; 2019 Dec; 15(1):3. PubMed ID: 31820121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of vitamin D and calcium supplementation on bone mineral density among Thai youth using daily HIV pre-exposure prophylaxis.
    Pornpaisalsakul K; Songtaweesin WN; Tepmongkol S; Wongharn P; Kawichai S; Suponsilchai V; Anugulruengkitt S; Puthanakit T;
    J Int AIDS Soc; 2020 Oct; 23(10):e25624. PubMed ID: 33040465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of calcium and vitamin D deficiency in HIV-positive men on tenofovir-containing antiretroviral therapy.
    Bech A; Van Bentum P; Telting D; Gisolf J; Richter C; De Boer H
    HIV Clin Trials; 2012; 13(6):350-6. PubMed ID: 23195673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D, parathyroid hormone levels and bone mineral density in community-dwelling older women: the Rancho Bernardo Study.
    von Mühlen DG; Greendale GA; Garland CF; Wan L; Barrett-Connor E
    Osteoporos Int; 2005 Dec; 16(12):1721-6. PubMed ID: 15928802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 16-weeks vitamin D replacement on calcium-phosphate homeostasis in overweight and obese adults.
    Mesinovic J; Mousa A; Wilson K; Scragg R; Plebanski M; de Courten M; Scott D; Naderpoor N; de Courten B
    J Steroid Biochem Mol Biol; 2019 Feb; 186():169-175. PubMed ID: 30367939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum 25-hydroxyvitamin D, parathyroid hormone, calcium intake, and bone mineral density in Spanish adults.
    Olmos JM; Hernández JL; García-Velasco P; Martínez J; Llorca J; González-Macías J
    Osteoporos Int; 2016 Jan; 27(1):105-13. PubMed ID: 26134682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical Response of Parathyroid Hormone to Vitamin D-Calcium Supplementation in Indian Children.
    Mandlik RM; Mughal ZM; Khadilkar AV; Ekbote VH; Kajale NA; Patwardhan VG; Khadilkar VV; Padidela R
    J Pediatr; 2020 Jan; 216():197-203. PubMed ID: 31704050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum 25-hydroxyvitamin D, parathyroid hormone, and bone mineral density in men: the Rancho Bernardo study.
    Saquib N; von Mühlen D; Garland CF; Barrett-Connor E
    Osteoporos Int; 2006 Dec; 17(12):1734-41. PubMed ID: 16967190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
    Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
    Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of switching from zidovudine to tenofovir disoproxil fumarate on bone mineral density and markers of bone metabolism in virologically suppressed HIV-1 infected patients; a substudy of the PREPARE study.
    Cotter AG; Vrouenraets SM; Brady JJ; Wit FW; Fux CA; Furrer H; Brinkman K; Sabin CA; Reiss P; Mallon PW;
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1659-66. PubMed ID: 23436922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.